BIOMAT Database Logo BIOMAT Database Logo

Plasma GABA predicts acute response to divalproex in mania. 1996

F Petty, and A J Rush, and J M Davis, and J R Calabrese, and S E Kimmel, and G L Kramer, and J G Small, and M J Miller, and A E Swann, and P J Orsulak, and M E Blake, and C L Bowden
Veterans Affairs Medical Center, Dallas, TX 75216, USA.

Bipolar I, manic phase inpatients were treated with divalproex sodium, lithium, or placebo in a previously reported parallel group multicenter, double-blind, randomized, controlled acute phase treatment trial. Plasma concentrations of gamma aminobutyric acid (GABA) were measured before and after treatment. Higher pretreatment plasma GABA levels were significantly (p = .04) related to a better clinical response to divalproex (n = 19). Pretreatment plasma GABA levels did not correlate with response to either lithium (n = 13) or placebo (n = 31). Following treatment with divalproex sodium, plasma GABA levels decreased significantly (p < .05), compared to placebo. Pretreatment plasma GABA levels were not related to overall severity of manic symptoms. Plasma GABA may predict response to pharmacologic agents acting on the GABA system.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid

Related Publications

F Petty, and A J Rush, and J M Davis, and J R Calabrese, and S E Kimmel, and G L Kramer, and J G Small, and M J Miller, and A E Swann, and P J Orsulak, and M E Blake, and C L Bowden
Classic mania: treatment response to divalproex or lithium.
November 1998, Archives of general psychiatry,
F Petty, and A J Rush, and J M Davis, and J R Calabrese, and S E Kimmel, and G L Kramer, and J G Small, and M J Miller, and A E Swann, and P J Orsulak, and M E Blake, and C L Bowden
Depression during mania. Treatment response to lithium or divalproex.
January 1997, Archives of general psychiatry,
F Petty, and A J Rush, and J M Davis, and J R Calabrese, and S E Kimmel, and G L Kramer, and J G Small, and M J Miller, and A E Swann, and P J Orsulak, and M E Blake, and C L Bowden
[Prediction of treatment response in acute mania: controlled clinical trials with divalproex].
January 2001, L'Encephale,
F Petty, and A J Rush, and J M Davis, and J R Calabrese, and S E Kimmel, and G L Kramer, and J G Small, and M J Miller, and A E Swann, and P J Orsulak, and M E Blake, and C L Bowden
Olanzapine versus divalproex in the treatment of acute mania.
June 2002, The American journal of psychiatry,
F Petty, and A J Rush, and J M Davis, and J R Calabrese, and S E Kimmel, and G L Kramer, and J G Small, and M J Miller, and A E Swann, and P J Orsulak, and M E Blake, and C L Bowden
Divalproex versus olanzapine in mania.
October 2003, The Journal of clinical psychiatry,
F Petty, and A J Rush, and J M Davis, and J R Calabrese, and S E Kimmel, and G L Kramer, and J G Small, and M J Miller, and A E Swann, and P J Orsulak, and M E Blake, and C L Bowden
Divalproex sodium increases plasma GABA levels in healthy volunteers.
July 2000, International clinical psychopharmacology,
F Petty, and A J Rush, and J M Davis, and J R Calabrese, and S E Kimmel, and G L Kramer, and J G Small, and M J Miller, and A E Swann, and P J Orsulak, and M E Blake, and C L Bowden
Divalproex sodium treatment in late adolescent and young adult acute mania.
January 1993, Psychopharmacology bulletin,
F Petty, and A J Rush, and J M Davis, and J R Calabrese, and S E Kimmel, and G L Kramer, and J G Small, and M J Miller, and A E Swann, and P J Orsulak, and M E Blake, and C L Bowden
Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo.
October 2005, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
F Petty, and A J Rush, and J M Davis, and J R Calabrese, and S E Kimmel, and G L Kramer, and J G Small, and M J Miller, and A E Swann, and P J Orsulak, and M E Blake, and C L Bowden
Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania.
April 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
F Petty, and A J Rush, and J M Davis, and J R Calabrese, and S E Kimmel, and G L Kramer, and J G Small, and M J Miller, and A E Swann, and P J Orsulak, and M E Blake, and C L Bowden
Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania.
August 1999, The American journal of psychiatry,
Copied contents to your clipboard!